Beijing Ql Biopharmaceutical Co.,ltd
Clinical trials sponsored by Beijing Ql Biopharmaceutical Co.,ltd, explained in plain language.
-
New obesity drug ZT002 tested for safety with other medications
Knowledge-focused Recruiting nowThis early-stage study looks at how ZT002, a long-acting experimental drug for weight management, affects the way the body processes four common medications (metformin, warfarin, rosuvastatin, and digoxin). About 60 overweight or obese but otherwise healthy adults aged 18-45 will…
Phase: PHASE1 • Sponsor: Beijing QL Biopharmaceutical Co.,Ltd • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Kidney patients get first look at new obesity drug
Knowledge-focused Recruiting nowThis early-stage study tests a single dose of Zovaglutide (ZT002), an experimental drug for overweight and obesity, in 40 adults with varying levels of kidney function. Researchers will measure how the drug moves through the body and check for side effects. The goal is to underst…
Phase: PHASE1 • Sponsor: Beijing QL Biopharmaceutical Co.,Ltd • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:09 UTC
-
New drug ZT003 tested for safety in first human trial
Knowledge-focused Recruiting nowThis early-stage study tests the safety and tolerability of an investigational drug called ZT003 in healthy adults and those who are overweight or obese. About 76 participants will receive either the drug or a placebo to check for side effects and how the drug moves through the b…
Phase: PHASE1 • Sponsor: Beijing QL Biopharmaceutical Co.,Ltd • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC